Veterinary telehealth in 2026: 94 million pet-owning households. A shortage of veterinarians. And a digital infrastructure finally ready to bridge the gap. 94 million pet-owning households. Not enough veterinarians to see them all. The structural demand case for veterinary telehealth begins with a simple arithmetic observation. The American Pet Products Association reported 94 million U.S. households owned a pet in 2025 - an all-time peak driven by the pandemic's adoption surge, with millennials and Gen Z demonstrating the strongest adoption rates and the highest average spending on pet care of any generational cohort. This expanded pet-owning population is pressing against a veterinary profession that has documented workforce capacity constraints: rural areas face particular shortages, urban practices are operating at or near capacity in many markets, and the cost and time required to train a veterinarian means supply cannot rapidly adjust to the demand increase that pandemic-era pet adoption created. The AVMA has consistently tracked veterinarian availability as a structural concern, and telehealth represents the most practically scalable mechanism for expanding access to professional veterinary advice without requiring new physical clinic infrastructure to be built. What veterinary telehealth can and cannot do: the clinical boundary that matters. Any honest assessment of veterinary telehealth must engage with the clinical boundary that defines its scope: the veterinarian-client-patient relationship, or VCPR, which most U.S. state regulations require to be established through in-person examination before a veterinarian can diagnose and prescribe treatment. This requirement - which varies by state, with some states permitting telemedicine to establish a valid VCPR and others requiring at least one prior in-person visit - shapes what veterinary telehealth platforms can offer and how they position themselves commercially. The most successful platforms have found genuine clinical value within this constraint: teletriage services that help owners determine whether a symptom requires urgent in-person care or can be safely monitored at home; behavioural consultations for anxiety, aggression, and training challenges that are genuinely addressable remotely; nutritional guidance and chronic condition monitoring for diseases such as diabetes that require ongoing management but not frequent in-person examination. The AVMA's telehealth guidance framework acknowledges the clinical complexity of the space while recognising telehealth's value in improving access, particularly for communities where the alternative to a remote consultation is no consultation at all. France's post-pandemic authorisation: A regulatory model taking shape in europe. The regulatory environment for veterinary telehealth has been evolving in parallel with the technology's capabilities. France made a notable step when authorities officially authorised French veterinarians to adopt telehealth into their practice following the pandemic - a regulatory decision that legitimised remote consultation as a standard care modality rather than an emergency exception. This mirrors the trajectory that human telemedicine has followed in multiple jurisdictions: emergency authorisation during the pandemic normalising into permanent regulatory frameworks that embed telehealth in standard care pathways. The pattern is not uniform globally: Asia-Pacific is expected to grow fastest in veterinary telehealth adoption precisely because regulatory frameworks in the region's rapidly expanding pet care markets are establishing new rules from scratch rather than retrofitting telehealth into existing veterinary practice acts designed before the technology existed. The platforms competing for the market: FirstVet, Vetster, Airvet, Chewy, and Fuzzy. The veterinary telehealth competitive landscape in 2026 is populated by a mix of purpose-built veterinary telehealth platforms and established pet retail players extending into health services. FirstVet operates across multiple European and North American markets with a subscription and per-consultation model. Vetster and Airvet compete directly for the U.S. companion animal market. Chewy has extended its pet retail dominance into veterinary telehealth, leveraging its existing customer relationships with tens of millions of pet-owning households. Fuzzy Pet Health operates a membership model combining telehealth access with broader pet care advisory services. The differentiation between these platforms is increasingly concentrated in three dimensions: the breadth and availability of their veterinary professional networks; the depth of their integration with digital diagnostic tools and wearable devices; and the user experience of their mobile applications, which determine whether a pet owner experiencing a 2am concern about their dog's breathing will actually complete a consultation or default to a general internet search. AI integration: from triage tool to diagnostic augmentation. The most consequential near-term development in veterinary telehealth is not the growth of the consultation volume - which is structurally secure given the pet ownership and veterinarian supply dynamics described above - but the quality improvement that AI integration is enabling in remote consultations. AI-driven symptom checkers capable of processing the owner's description of clinical signs alongside uploaded images or video clips of the animal are improving triage accuracy. Vetology's commitment to transparent AI performance metrics, described in detail in the Pet Tech blog above, reflects the direction the field is moving: AI that can be validated, trusted, and integrated into clinical workflows rather than AI that generates outputs without documented accuracy. The convergence of AI diagnostics with wearable device data streams - a collar-mounted heart rate and temperature sensor feeding continuous biometric data into a telehealth platform that a remote veterinarian can access during a consultation - represents the emerging standard for what a remote veterinary visit can accomplish in 2026 versus what it could accomplish three years ago. The rural access argument: telehealth's most defensible use case. The veterinary telehealth market's most socially compelling use case - and in many ways its most defensible from a health outcome perspective - is expanding access to professional veterinary advice in rural and underserved communities where the nearest veterinary clinic may be a one to two hour drive and operating near capacity. Research on the U.S. market has consistently identified rural access as a primary unmet need in veterinary care: livestock owners, in particular, depend on veterinary guidance for herd health management decisions that have significant economic consequences, and the shortage of large animal veterinarians in rural areas is a documented and worsening trend. For companion animals in rural households, the telehealth triage service that helps an owner determine at 10pm whether their dog needs emergency care tonight or can wait for a morning appointment has a straightforward and significant quality-of-life value. The technology is ready. The platforms exist. The commercial model is being refined. The remaining constraint - regulatory clarity around VCPR establishment via telemedicine - is the variable that most directly determines how quickly the rural access use case can be realised at scale. What veterinary telehealth looks like when the regulatory framework catches up. Constancy Researchers' assessment: veterinary telehealth in 2026 sits at a structurally favourable intersection of demand pressure, technological readiness, and evolving regulatory frameworks. The 94 million U.S. pet-owning households, combined with the documented veterinarian supply constraint, create a structural access gap that telehealth is uniquely positioned to address. The platforms competing for this market - FirstVet, Vetster, Airvet, Chewy, Fuzzy, and others - are building the professional network depth, AI integration, and mobile application quality that will determine which organisations earn the trust of both pet owners and veterinary professionals as the primary channel for remote animal health consultation. The market's regulatory environment, while still fragmented across U.S. states and international jurisdictions, is moving in a broadly supportive direction. The risk that veterinary telehealth will not scale is not primarily technological or demand-based. It is regulatory - and regulatory frameworks, as human telemedicine's post-pandemic trajectory has demonstrated, have a reliable long-run tendency to adapt to the clinical realities that practitioners and patients are already living with. Looking to navigate geopolitical risks and identify new industry opportunities? Connect with Constancy Researchers for data-driven insights, geopolitical intelligence, and strategic consulting tailored to your business needs. Contact Constancy Researchers Private Limited. Constancy Researchers August 5, 2026 Constancy Researchers August 3, 2026

Wrap up: The pet insurance gap persists even as enrollment grows, and other news. Here are this week's headlines Happy Friday, dvm360 readers! Fresh off the 2026 AVMA Convention in Anaheim, this week's lineup pairs a hard look at the insurance gap with clinical guidance and practice-level insight from the show floor. Leading things off, a new found that US pet insurance enrollment rose 9% in 2025, yet more than 95% of the country's cats and dogs remain uninsured even as veterinary costs keep climbing, with gastrointestinal issues, ear infections, and skin conditions driving many of the claims that were filed. Here is what else came out this week on dvm360.com: * Ellen Behrend, VMD, MS, PhD, DACVIM (SAIM), spoke with dvm360 during the 2026 AVMA Convention to make the case that SGLT2 inhibitors are safer, easier to use, and often cheaper for owners than many practitioners assume, in this on patient selection, ketone monitoring, and diet in cats with diabetes. * On this week's of The Vet Blast Podcast presented by dvm360, Ori Stollar M.Sc., DVM, DACVB, joins host Adam Christman, DVM, MBA, to break down 5 stress signals in dogs and cats that are easy to miss in the exam room, and when it's time to refer to a behaviorist. * At the AVMA Convention, Anita Patel, DVM, senior director of clinical excellence at IndeVets, why transparency and solution-oriented feedback from technicians, veterinarians, and practice managers can shape better organizational decisions. * In this week's Paws and profits, Fear Free its first chief veterinary officer, Exubrion Therapeutics promoted a new chief commercial officer, and Phillips Pet Food & Supplies announced a CEO transition. * And in clinic news, a has been proposed for Ellis County, Texas, following last year's SPCA closure, while Chewy Vet Care opened its first North Florida practice in Jacksonville. * And more!

Chewy reported 8% sales growth in its latest quarter, reaching $3.3 billion in revenue for the period ended May 2026, whilst maintaining a net income margin of approximately 1%. The online pet retailer launched a consolidated private-label brand called Chewy Made. In contrast, Petco Health and Wellness saw flat revenue at $1.5 billion for the quarter ended May 2026, though it posted a 38% gross margin and returned to positive comparable-store sales growth. Chewy trades at 0.7 times sales and maintains a slight net cash position. Petco trades at 0.12 times sales but carries $2.3 billion in debt against a market capitalisation of $750 million, making it more financially vulnerable.